Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Weather
2 NC counties are under alert, including Johnston County.
Breaking News
Food truck hit by gunfire in Raleigh
Program
It's time for football! Tune to WRAL-TV to catch all the Week 1 highlights on Football Friday
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Axogen Inc
(NQ:
AXGN
)
12.52
+0.17 (+1.38%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
276,158
Open
12.45
Bid (Size)
11.58 (1)
Ask (Size)
12.95 (3)
Prev. Close
12.35
Today's Range
12.31 - 12.68
52wk Range
3.450 - 13.03
Shares Outstanding
41,397,053
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
CytoSorbents Appoints Peter J. Mariani Chief Financial Officer
August 13, 2024
CytoSorbents CFO Kathleen P. Bloch Retires
From
CytoSorbents
Via
GlobeNewswire
AXGN Stock Earnings: Axogen Beats EPS, Beats Revenue for Q2 2024
August 08, 2024
AXGN stock results show that Axogen beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Performance
YTD
+81.19%
+81.19%
1 Month
+35.06%
+35.06%
3 Month
+99.68%
+99.68%
6 Month
+20.73%
+20.73%
1 Year
+98.10%
+98.10%
More News
Read More
Parker-Hannifin Posts Upbeat Earnings, Joins Under Armour, Zillow Group, YETI Holdings, Eli Lilly And Other Big Stocks Moving Higher On Thursday
August 08, 2024
Via
Benzinga
Axogen Earnings Preview
March 04, 2024
Via
Benzinga
Axogen, Inc. Announces New Leadership Appointments
August 08, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc. Reports Second Quarter 2024 Financial Results
August 08, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc. to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024
July 23, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Company Reports Inducement Grants to Non-Executive New Employee Under Nasdaq Listing Rule 5635(C)(4)
July 01, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix™
June 24, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Axogen Processing Center (APC) Celebrates its Opening with Ohio Leaders in Vandalia
May 28, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Axogen Inc. Initiates Rolling Submission of Biologics License Application to U.S. Food and Drug Administration (FDA) for Avance Nerve Graft®
May 16, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc to Participate at Leerink Partners Healthcare Crossroads Conference
May 14, 2024
From
Axogen, Inc.
Via
GlobeNewswire
AXGN Stock Earnings: Axogen Beats EPS, Misses Revenue for Q1 2024
May 02, 2024
Via
InvestorPlace
Axogen, Inc Reports First Quarter 2024 Financial Results
May 02, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™
April 29, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024
April 16, 2024
From
Axogen, Inc.
Via
GlobeNewswire
AXGN Stock Earnings: Axogen Beats EPS, Beats Revenue for Q4 2023
March 05, 2024
Via
InvestorPlace
Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial Results
March 05, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 05, 2024
Via
Benzinga
Axogen, Inc. to Report 2023 Fourth Quarter and Full-Year Financial Results on March 5, 2024
February 13, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Earnings Scheduled For March 5, 2024
March 05, 2024
Via
Benzinga
Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
February 02, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc. Announces Positive Topline Results from REPOSE, a Prospective, Randomized Clinical Trial of Axoguard Nerve Cap
January 18, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Crude Oil Rises Over 2%; Constellation Brands Posts Downbeat Sales
January 05, 2024
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
January 05, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.